Brinzolamide Suspension/ Drops
Product Images NDC 0781-6014

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brinzolamide (NDC 0781-6014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical (Chemical)

Chemical structure of Brinzolamide, illustrating its molecular composition including functional groups and stereochemistry as depicted in the diagram.*

FDA Label Image

Francecarton

Label of Brinzolamide Ophthalmic Suspension 1% sterile 10 mL by Sandoz Inc. The label shows the drug name, concentration (1%), form as ophthalmic suspension, prescription only status, and storage instructions. Ingredients and warnings for topical ophthalmic use are visible, along with manufacturer information from Alcon Laboratories and Sandoz Inc. The label includes barcodes and serialization details.*

FDA Label Image

Switzerlandcarton

Packaging label for Brinzolamide Ophthalmic Suspension 1%, a prescription eye drop suspension by Sandoz Inc. The label states the product is sterile, 10 mL in volume, and includes usage instructions, warnings, storage conditions, and manufacturing details. It lists benzalkonium chloride as preservative and provides barcode and lot information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.